glp-1 digital health platforms startups

glp-1 digital health platforms startups Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study Novo Nordisk seeks digital health

Name: glp-1 digital health platforms startups Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study Novo Nordisk seeks digital health
Brand: www.keygrove.com
SKU: 5325664474
Price: 20.88 USD
Availability: InStock
Rating: 4.3312 (19 reviews)

SKU: 5325664474

4.3

USD20.88 USD45.88

Pay in 4 interest-free payments of $5.22 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

N Engl J Med 360: 18271838

(PubMed) Klein EA, Thompson IM, Jr., Tangen CM, et al

(26) This retrospective cohort study included 74,475 patients with type 2 diabetes taking either an SGLT2-I, GLP-1, or sulfonylurea, with sulfonylureas serving as the reference group